Patent Foramen Ovale (PFO) Closure From Strokes to Migraines ...
Patent Foramen Ovale (PFO) Closure From Strokes to Migraines ...
Patent Foramen Ovale (PFO) Closure From Strokes to Migraines ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The PREMIUM Trial<br />
A Randomized Double Blind Trial of <strong>PFO</strong> <strong>Closure</strong><br />
for Disabling Migraine Headaches (6-14 days/mo)<br />
230 patients with migraine ± aura<br />
assess for <strong>PFO</strong> with TCD, if +, TTE<br />
randomize<br />
Usual HA Rx +<br />
ASA & Plavix +<br />
Sham Procedure<br />
Usual HA Rx +<br />
ASA & Plavix +<br />
<strong>PFO</strong> <strong>Closure</strong><br />
Recent approval by FDA of less restrictive entry criteria<br />
And control patients can have <strong>PFO</strong> closure after 1 year.<br />
Monday, December 7, 2009
Change language